Sugi Predict

Sugi Predict / Compounds / SCHEMBL574645

SCHEMBL574645

SCHEMBL574645

N=C(N)NCC[C@H](N)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PMP22 Q01453 2/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ GSR P00390 2/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ GRM8 O00222 1/20 0.45
▸ GRM6 O15303 1/20 0.45
▸ GRIN2D O15399 1/20 0.45
▸ GRIN3B O60391 1/20 0.45
▸ GRIK1 P39086 1/20 0.45
▸ GRM5 P41594 1/20 0.45
▸ GRIA1 P42261 1/20 0.45
▸ GRIA2 P42262 1/20 0.45
▸ GRIA3 P42263 1/20 0.45
▸ SLC1A3 P43003 1/20 0.45
▸ SLC1A2 P43004 1/20 0.45
▸ SLC1A1 P43005 1/20 0.45
▸ GRIA4 P48058 1/20 0.45
▸ GRIN1 Q05586 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL466338 1.00 PMP22 (0.48) PMP22ALOX15BLMKMT2AGSR
SCHEMBL1527399 1.00 PMP22 (0.48) PMP22ALOX15BLMKMT2AGSR
Alanine SCHEMBL6762705 0.93 NOS3 (0.44) PMP22ALOX15BLMKMT2AGSR
Alanine SCHEMBL6762703 0.93 NOS3 (0.44) PMP22ALOX15BLMKMT2AGSR
Adipic Acid SCHEMBL8058451 0.89 BHMT (0.50) PMP22ALOX15BLMKMT2AGSR
Arginine SCHEMBL6374054 0.88 OTC (0.56) PMP22ALOX15BLMKMT2AGSR
Arginine SCHEMBL288132 0.88 OTC (0.56) PMP22ALOX15BLMKMT2AGSR
Arginine SCHEMBL2411547 0.88 OTC (0.56) PMP22ALOX15BLMKMT2AGSR
Arginine SCHEMBL7928810 0.88 OTC (0.56) PMP22ALOX15BLMKMT2AGSR
Arginine SCHEMBL1790 0.88 OTC (0.56) PMP22ALOX15BLMKMT2AGSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702986-A1 POLYPEPTIDE AND USE THEREOF Biocells (Beijing) Biotech Co., Ltd. (CN) 2026-03-04 — — EP claimed
US-12521455-B2 Kisspeptin receptor (KISS1R) targeted therapeutics and uses thereof RADIONETICS ONCOLOGY, INC. (US) 2026-01-13 — — US claimed
US-20260001922-A1 PEPTIDES TARGETING SODIUM CHANNELS TO TREAT PAIN UNIV CALIFORNIA (US) 2026-01-01 — — US claimed
WO-2025217074-A1 KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF RADIONETICS ONCOLOGY, INC. (US) 2025-10-16 — — WO claimed
US-20250312499-A1 KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF RADIONETICS ONCOLOGY, INC. 2025-10-09 — — US claimed
US-20250282819-A1 MITOCHONDRIA-SPECIFIC PEPTIDE THAT CAN BE INTRACELLULARLY DELIVERED AT NANOMOLAR CONCENTRATION, AND USE THEREOF CAMP THERAPEUTICS INC. (KR) 2025-09-11 — — US claimed
US-20250237649-A1 COMPOSITIONS AND METHODS FOR HIP1-TARGETING INHIBITOR COMPOUNDS UTAH VALLEY UNIVERSITY 2025-07-24 — — US claimed
CN-120022230-A Peroxide hydrogel and preparation method thereof 千氧生物技术(上海)有限公司 2025-05-23 — — CN claimed
WO-2025094120-A1 CATIONIC PEPTIDES WITH BROAD SPECTRUM ACTIVITY THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2025-05-08 — — WO claimed
WO-2024253439-A1 COMPOSITIONS FOR PREVENTING OR TREATING OBESITY OR NON-ALCOHOLIC FATTY LIVER DISEASE COMPRISING MITOCHONDRIA-SPECIFIC PEPTIDES (주) 캠프테라퓨틱스 2024-12-12 — — WO claimed
WO-2022129627-A1 OLIGOMERIC COMPOUNDS BINDING SPECIFICALLY TO PROTEOGLYCANS PHI PHARMA SA (CH) 2022-06-23 — — WO claimed
EP-4015004-A1 PROTEOGLYCAN SPECIFIC BRANCHED PEPTIDES Phi Pharma SA (CH) 2022-06-22 — — EP claimed
CN-114599375-A Nucleic acid delivery promoter 国立大学法人高知大学 2022-06-07 — — CN claimed
US-20210138025-A1 CATIONIC PEPTIDES WITH IMMUNOMODULATORY AND/OR ANTI-BIOFILM ACTIVITIES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2021-05-13 — — US claimed
WO-2021080020-A1 NUCLEIC ACID DELIVERY ENHANCER 国立大学法人高知大学 2021-04-29 — — WO claimed
EP-3743434-A1 CATIONIC PEPTIDES WITH IMMUNOMODULATORY AND/OR ANTI-BIOFILM ACTIVITIES The University of British Columbia (CA) 2020-12-02 — — EP claimed
WO-2019179985-A1 INHIBITORS OF MINT AND USES THEREOF UNIVERSITY OF COPENHAGEN (DK) 2019-09-26 — — WO claimed
WO-2019145913-A1 CATIONIC PEPTIDES WITH IMMUNOMODULATORY AND/OR ANTI-BIOFILM ACTIVITIES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2019-08-01 — — WO claimed
US-8524659-B2 RNA virus-derived peptides with modified side chains NATIONAL TAIWAN UNIVERSITY (TW) 2013-09-03 — — US claimed
US-20130109618-A1 RNA VIRUS-DERIVED PEPTIDES WITH MODIFIED SIDE CHAINS NATIONAL TAIWAN UNIVERSITY (TW) 2013-05-02 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001922-A1 PEPTIDES TARGETING SODIUM CHANNELS TO TREAT PAIN TPX2, XBP1, SCN9A PMP22 1086/4885ALOX15 3239/4885BLM 1380/4885
US-20250312499-A1 KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF KISS1R, GNRHR, PROKR1 PMP22 3513/4885ALOX15 4665/4885BLM 4627/4885
US-20210138025-A1 CATIONIC PEPTIDES WITH IMMUNOMODULATORY AND/OR ANTI-BIOFILM ACTIVITIES ARG1, LGALS3BP, MIF PMP22 4337/4885ALOX15 2387/4885BLM 1900/4885
US-20250237649-A1 COMPOSITIONS AND METHODS FOR HIP1-TARGETING INHIBITOR COMPOUNDS HIPK1, HIPK3, HIPK2 PMP22 4309/4885ALOX15 4064/4885BLM 3940/4885
US-20130109618-A1 RNA VIRUS-DERIVED PEPTIDES WITH MODIFIED SIDE CHAINS SARS1, SARNP, EIF2AK2 PMP22 2657/4885ALOX15 4772/4885BLM 2480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.